Core Viewpoint - Rakuten Medical, a cancer treatment developer partially owned by Japan's Rakuten Group, has successfully completed a fundraising round to expedite the approval process for its cancer treatment in the U.S. [1] Company Summary - Rakuten Medical is focused on developing innovative cancer therapies and is leveraging recent funding to enhance its operational capabilities and regulatory approval timeline in the U.S. [1]